Budelite 1mg 2ml Respule

The Budelite 1mg 2ml Respule is a pharmaceutical product containing Budesonide 1.0mg, a potent corticosteroid formulated as a sterile, preservative-free aqueous suspension for nebulization. Designed for inhalation therapy, this product delivers targeted anti-inflammatory action directly to the airways, making it an essential component in the management of various respiratory conditions.

Primarily indicated for the maintenance treatment of bronchial asthma and chronic obstructive pulmonary disease (COPD), Budelite 1mg 2ml Respule works by reducing inflammation and swelling in the lungs, thereby improving airflow and easing breathing difficulties. It is also utilized as prophylactic therapy in children aged 12 months to 8 years and in the management of acute laryngotracheobronchitis (croup) in infants and children. This medication is intended for regular, long-term control and is not indicated for the relief of acute bronchospasm.

Administered via a standard nebulizer system, the Budelite 1mg 2ml Respule ensures efficient delivery of the active ingredient to the smallest airways. Its single-dose unit design promotes hygiene and accurate dosing, crucial for patient safety and therapeutic efficacy in hospital pharmacies, respiratory clinics, and primary care settings. Post-administration, patients are advised to rinse their mouth with water to mitigate potential side effects such as oral thrush.

Key Features : 

Active Ingredient: Budesonide 1.0mg per 2ml respule, a trusted corticosteroid.
Formulated for Nebulization: Ensures direct and efficient delivery to the respiratory tract.
Targeted Anti-Inflammatory Action: Reduces airway inflammation and swelling.
Indicated for Chronic Respiratory Conditions: Suitable for long-term management of asthma and COPD.
Prophylactic Use: Helps reduce the frequency and severity of respiratory flare-ups.
Sterile & Preservative-Free: Aqueous suspension in single-dose units for enhanced safety and sterility.
Broad Patient Applicability: Effective for both adult and pediatric use (ages 12 months to 8 years for asthma prophylaxis, under medical supervision).
Compatible with Standard Nebulizers: Integrates seamlessly into existing clinical setups.